|
Name |
Methyl (2-methoxyphenyl)acetate
|
Molecular Formula | C10H12O3 | |
IUPAC Name* |
methyl 2-(2-methoxyphenyl)acetate
|
|
SMILES |
COC1=CC=CC=C1CC(=O)OC
|
|
InChI |
InChI=1S/C10H12O3/c1-12-9-6-4-3-5-8(9)7-10(11)13-2/h3-6H,7H2,1-2H3
|
|
InChIKey |
BNQRSYFOIRGRKV-UHFFFAOYSA-N
|
|
Synonyms |
27798-60-3; Methyl 2-Methoxyphenylacetate; methyl 2-(2-methoxyphenyl)acetate; Methyl (2-methoxyphenyl)acetate; 2-Methoxyphenylacetic Acid Methyl Ester; Methyl o-methoxyphenylacetate; 2-Methoxyphenylacetic acid methyl; Benzeneacetic acid, 2-methoxy-, methyl ester; MFCD02093479; K3NWF99XPP; NSC-245109; EINECS 248-662-1; UNII-K3NWF99XPP; Acetic acid, (o-methoxyphenyl)-, methyl ester; methyl a-methoxyphenylacetate; Methyl 2-methoxybenzeneacetate; SCHEMBL468013; methyl(2-methoxyphenyl)acetate; Methyl 2-methoxy-benzeneacetate; SCHEMBL6554270; DTXSID60182119; CBA79860; ZINC1765758; NSC245109; AKOS000296288; AM84149; NSC 245109; s11983; (2-methoxyphenyl)acetic acid methyl ester; AS-66129; SY053750; Methyl ester of o-Methoxyphenylacetic acid; DB-047279; (2-Methoxy-phenyl)-acetic acid methyl ester; CS-0083149; FT-0638724; M1329; EN300-748915; 2-METHOXY PHENYL ACETIC ACID METHYL ESTER; A819197; 2-Hydroxyphenylacetic acid, methyl ether, methyl ester
|
|
CAS | 27798-60-3 | |
PubChem CID | 99590 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 180.2 | ALogp: | 1.8 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 35.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.666 |
Caco-2 Permeability: | -4.399 | MDCK Permeability: | 0.00003670 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.904 |
Blood-Brain-Barrier Penetration (BBB): | 0.992 | Plasma Protein Binding (PPB): | 55.65% |
Volume Distribution (VD): | 0.62 | Fu: | 26.53% |
CYP1A2-inhibitor: | 0.846 | CYP1A2-substrate: | 0.725 |
CYP2C19-inhibitor: | 0.859 | CYP2C19-substrate: | 0.862 |
CYP2C9-inhibitor: | 0.163 | CYP2C9-substrate: | 0.658 |
CYP2D6-inhibitor: | 0.022 | CYP2D6-substrate: | 0.704 |
CYP3A4-inhibitor: | 0.133 | CYP3A4-substrate: | 0.561 |
Clearance (CL): | 11.151 | Half-life (T1/2): | 0.898 |
hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.389 |
Drug-inuced Liver Injury (DILI): | 0.786 | AMES Toxicity: | 0.057 |
Rat Oral Acute Toxicity: | 0.062 | Maximum Recommended Daily Dose: | 0.012 |
Skin Sensitization: | 0.403 | Carcinogencity: | 0.422 |
Eye Corrosion: | 0.661 | Eye Irritation: | 0.862 |
Respiratory Toxicity: | 0.085 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000208 | 0.523 | D0FN7J | 0.407 | ||||
ENC002235 | 0.500 | D0GY5Z | 0.365 | ||||
ENC000033 | 0.452 | D09VXM | 0.338 | ||||
ENC000299 | 0.423 | D0N3UL | 0.327 | ||||
ENC000391 | 0.412 | D02YYF | 0.315 | ||||
ENC004860 | 0.408 | D07HBX | 0.313 | ||||
ENC001333 | 0.404 | D02XJY | 0.308 | ||||
ENC000409 | 0.404 | D0T3NY | 0.305 | ||||
ENC000303 | 0.404 | D0E6OC | 0.304 | ||||
ENC000104 | 0.404 | D0X9RY | 0.298 |